Drug Shortage Report for TEGRETOL SUSPENSION
| Report ID | 235981 |
| Drug Identification Number | 02194333 |
| Brand name | TEGRETOL SUSPENSION |
| Common or Proper name | TEGRETOL SUSPENSION 100MG/5ML 450 ML |
| Company Name | NOVARTIS PHARMACEUTICALS CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | CARBAMAZEPINE |
| Strength(s) | 100MG |
| Dosage form(s) | SUSPENSION |
| Route of administration | ORAL ORAL |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 450 ML |
| ATC code | N03AF |
| ATC description | ANTIEPILEPTICS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2024-11-04 |
| Actual start date | |
| Estimated end date | 2024-11-25 |
| Actual end date | 2024-11-25 |
| Shortage status | Resolved |
| Updated date | 2024-11-26 |
| Company comments | Product on allocation to minimize patient impact. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 700 RUE SAINT-HUBERT MONTREAL, QUEBEC CANADA H2Y 0C1 |
| Company contact information | [email protected] |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v13 | 2024-11-26 | English | Compare |
| v12 | 2024-11-25 | French | Compare |
| v11 | 2024-11-25 | English | Compare |
| v10 | 2024-11-05 | English | Compare |
| v9 | 2024-10-31 | French | Compare |
| v8 | 2024-10-31 | English | Compare |
| v7 | 2024-10-17 | English | Compare |
| v6 | 2024-10-10 | French | Compare |
| v5 | 2024-10-10 | English | Compare |
| v4 | 2024-10-02 | English | Compare |
| v3 | 2024-08-27 | French | Compare |
| v2 | 2024-08-27 | French | Compare |
| v1 | 2024-08-27 | English | Compare |
Showing 1 to 13 of 13